Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 |
| Revenues | 631.5 | 801.7 | 519.0 | 533.3 | 702.0 |
| Revenue growth | -21.2% | 54.5% | -2.7% | -24.0% | |
| Cost of goods sold | 451.1 | 530.8 | 402.3 | 377.6 | 498.5 |
| Gross profit | 180.5 | 270.9 | 116.7 | 155.7 | 203.5 |
| Gross margin | 28.6% | 33.8% | 22.5% | 29.2% | 29.0% |
| Research and development | | 28.4 | 27.3 | 27.1 | 23.0 |
| General and administrative | 20.2 | 665.8 | 462.8 | 617.7 | 749.2 |
| EBITA | -47.7 | 73.2 | -8.0 | -148.5 | -100.8 |
| EBITA margin | -7.6% | 9.1% | -1.5% | -27.8% | -14.4% |
| Amortization of intangibles | | 6.6 | 6.6 | 6.6 | 6.6 |
| EBIT | -47.7 | 66.6 | -14.6 | -155.1 | -107.4 |
| EBIT margin | -7.6% | 8.3% | -2.8% | -29.1% | -15.3% |
| Pre-tax income | -21.4 | 23.0 | -20.9 | -161.6 | -123.2 |
| Income taxes | 10.3 | 18.9 | 3.5 | 2.4 | 2.5 |
| Tax rate | | 82.5% | | | |
| Net income | -31.7 | -9.4 | -24.3 | -164.0 | -125.8 |
| Net margin | -5.0% | -1.2% | -4.7% | -30.8% | -17.9% |
| |
| Diluted EPS | ($0.35) | ($0.10) | ($0.80) | ($23.87) | |
| Shares outstanding (diluted) | 89.8 | 92.7 | 30.3 | 6.9 | |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|